Pew-funded partnership to tackle aging and longevity
September 16, 2021
Elçin Ünal and Gloria Brar, associate professors of molecular and cell biology, have been named 2021 Innovation Fund investigators by the Pew Charitable Trusts.
News
How to make plastic truly biodegradable
September 07, 2021
UC Berkeley’s Ting Xu and her students have come up with one solution for the global problem of single-use plastics: embed enzymes in the plastic, so that once the bag or cup is no longer wanted, it will self-destruct with a little heat and water.
Using two CRISPR enzymes, a COVID diagnostic in only 20 minutes
August 09, 2021
In efforts to develop a COVID-19 diagnostic test faster than qRT-PCR, a research team led by QB3-Berkeley affiliates Jennifer Doudna, David Savage, and Patrick Hsu have combined two different types of CRISPR enzymes to create an assay that can detect small amounts of viral RNA in less than an hour.
Global plastic pollution: How are we doing and where are we going?
July 28, 2021
Scientific interventions for tackling humanity’s addiction to plastic are hoping to make breakthroughs that could help restore the environment in a post-pandemic future.
Berkeley startup aims to be a game changer in autoimmune disease therapy
July 26, 2021
In January 2020, Marco Lobba had developed a new way of fusing proteins together that he thought could help treat autoimmune diseases like lupus, multiple sclerosis or Type 1 diabetes. A year later, he and Geo Guillen remotely launched Catena Biosciences, turning the potentially lifesaving idea into a successful company.
A mouth full of microbes: UC Berkeley researchers discover compound that can cause tooth decay
July 21, 2021
Chemical biologists in the Wenjun Zhang Lab at the University of California, Berkeley, have discovered compound mutanofactin-697. This compound is crucial in the development of cavities induced by Streptococcus mutans and may serve as a target in the prevention and treatment of dental caries.
Public health expert: ‘We need to go forward to a new type of normal’
June 24, 2021
QB3-Berkeley affiliate and public health expert Lee Riley addresses state reopening plans, the effectiveness of the COVID-19 vaccine against variants, health inequities that have been exposed by the pandemic, and moving forward to “a new type of normal.”
His monuments stand tall: Harry Stark retires after 18 years at UC Berkeley
June 24, 2021
UC Berkeley celebrates the retirement of Harry Stark after 18 years as director of facilities and engineering for the Vice Chancellor for Research.